A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Clinical trial NCT05312632 · COMPLETED
Trial details
- NCT number
- NCT05312632
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2023-05-25
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.